Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C

Abstract

Hypothyroidism was the most frequent TD, especially during the first cycle of α-interferon. Genotype 1 virus was associated with a risk two times higher for developing the illness. There was no need to interrupt or to change HCV treatment. Therefore, approximately 34% of TD was transient.